| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Dec 7, 2019Virtual Press Office and PR Newswire: General Trade show news
AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced results of a 7.5-year pooled analysis showing earlier treatment with IMBRUVICA® (ibrutinib) monotherapy...
-
Dec 7, 2019Virtual Press Office and PR Newswire: General Trade show news
Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies, announced...
-
Dec 7, 2019Virtual Press Office and PR Newswire: General Trade show news
AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced new data from the Phase 2 CAPTIVATE (PCYC-1142) clinical trial,1 evaluating IMBRUVICA® (ibrutinib) in...
-
Dec 7, 2019Virtual Press Office and PR Newswire: General Trade show news
Ceribell, Inc announced the launch of Clarity, a new 24/7 bedside EEG monitoring and alerting technology, at the American Epileptology Society Annual Meeting. Ceribell's Rapid Response EEG system...
-
Dec 6, 2019Virtual Press Office and PR Newswire: General Trade show news
Trial lawyers at Kaster, Lynch, Farrar & Ball are named among the finalists for the National Law Journal's Elite Trial Lawyers "Law Firm of the Year" for products liability litigation based on a...
